Skip to main content
Log in

Metabolic syndrome, adipokines and ghrelin in overweight and obese schoolchildren: results of a 1-year lifestyle intervention programme

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the effect of a lifestyle intervention programme (nutrition and exercise counselling) on metabolic syndrome (MS) components, adipokines (leptin, adiponectin) and ghrelin levels in overweight children. A total of 61 overweight children aged 7–9 years (≥85th body mass index (BMI) percentile; 27 boys/34 girls) were randomly assigned and completed a 1-year individual (IT) or group-based treatment (GT). Anthropometric and biochemical parameters were assessed at baseline, at 6 months and at 1 year. Twenty-two normal weight children (<85th BMI percentile; 7–9 years old; 13 boys/nine girls) were also evaluated at baseline. Insulin resistance (IR) was determined by the homeostasis model assessment of IR (HOMA-IR). Overweight children presented significantly higher blood pressure, triglycerides, apolipoprotein B, insulin, HOMA-IR, leptin, C-reactive protein and homocysteine levels, while apolipoprotein A-I was significantly lower. At baseline, MS was present in ten overweight children, of which only five maintained it at 1 year. Leptin and ghrelin levels were associated with IR and MS components. MS was predicted by apolipoprotein A-I, insulin and pre-puberty. The lifestyle intervention led to a significant improvement in standard deviation score of BMI, waist circumference/height ratio and lipid profile. Changes in insulin, HOMA-IR, leptin and adiponectin were not significant. Ghrelin behaved differently between IT and GT. The GT intervention seems to be more successful, with a decrease in BMI Z-score and an improvement of metabolic parameters. In conclusion, overweight children have multiple risk factors associated with MS. A lifestyle intervention programme seems to be an effective mean for reducing obesity and MS components and improving adipokines concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

BP:

Blood pressure

CDC:

Centers of Disease Control

CRP:

C-reactive protein

CVD:

Cardiovascular diseases

GT:

Group-based treatment

HDL:

High-density lipoprotein

HOMA-IR:

Homeostasis model assessment of insulin resistance

IT:

Individual treatment

MS:

Metabolic syndrome

SD:

Standard deviation

TG:

Triglycerides

WC:

Waist circumference

zBMI:

Standard deviation score of body mass index

References

  1. Bacha F, Arslanian SA (2005) Ghrelin suppression in overweight children: a manifestation of insulin resistance? J Clin Endocrinol Metab 90:2725–2730

    Article  PubMed  CAS  Google Scholar 

  2. Bobbert T, Rochlitz H, Wegewitz U et al (2005) Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54:2712–2719

    Article  PubMed  CAS  Google Scholar 

  3. Centers for Disease Control and Prevention. CDC growth charts: United States. Percentile data files with LMS values. http://www.cdc.gov/growthcharts/zscore.htm. Accessed 13 Jan 2004

  4. Cook S, Weitzman M, Auinger P et al (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157:821–827

    Article  PubMed  Google Scholar 

  5. Cruz ML, Goran MI (2004) The metabolic syndrome in children and adolescents. Curr Diab Rep 4:53–62

    Article  PubMed  Google Scholar 

  6. Dandona P, Alijada A, Chaudhuri A et al (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448–1454

    Article  PubMed  Google Scholar 

  7. De Ambrogi M, Volpe S, Tamanini C (2003) Ghrelin: central and peripheral effects of a novel peptydil hormone. Med Sci Monit 9:R217–R224

    Google Scholar 

  8. Dietz WH (1998) Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101:518–525

    PubMed  CAS  Google Scholar 

  9. Dubose KD, Stewart EE, Charbonneau SR et al (2006) Prevalence of the metabolic syndrome in elementary school children. Acta Pediatr 95:1005–1011

    Article  Google Scholar 

  10. Garipağaoğlu M, Sahip Y, Darendeliler F et al (2009) Family-based group treatment versus individual treatment in the management of childhood obesity: randomized, prospective clinical trial. Eur J Pediatr 168:1091–1099

    Article  PubMed  Google Scholar 

  11. Gilardini L, McTernan PG, Girola A et al (2006) Adiponectin as a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 189:401–407

    Article  PubMed  CAS  Google Scholar 

  12. Gil-Campos M, Aguilera CM, Cañete R, Gil A (2006) Ghrelin: a hormone regulating food intake and energy homeostasis. Br J Nutr 96:201–226

    Article  PubMed  CAS  Google Scholar 

  13. Goran MI, Gower BA (2001) Longitudinal study on pubertal insulin resistance. Diabetes 50:2444–2450

    Article  PubMed  CAS  Google Scholar 

  14. Han R, Lai R, Ding Q et al (2007) Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 50:1960–1968

    Article  PubMed  CAS  Google Scholar 

  15. Hoffstedt J, Arvidsson E, Sjölin E et al (2004) Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab 89:1391–1396

    Article  PubMed  CAS  Google Scholar 

  16. Huang TTK, Nansel TR, Belsheim AR, Morrison JA (2008) Sensitivity, specificity, and predictive values of pediatric metabolic syndrome components in relation to adult metabolic syndrome: The Princeton LCR Follow-up Study. J Pediatr 152:185–190

    Article  PubMed  Google Scholar 

  17. Johnston CA, Tyler C, McFarlin BK et al (2007) Weight loss in overweight Mexican American children: a randomized, controlled trial. Pediatrics 120:e1450–e1457

    Article  PubMed  Google Scholar 

  18. Kelishadi R, Hashemipour M, Mohammadifard N et al (2008) Short- and long-term relationships of serum ghrelin with changes in body composition and the metabolic syndrome in prepubescent obese children following two different weight loss programmes. Clin Endocrinol 69:721–729

    Article  CAS  Google Scholar 

  19. Klimcakova E, Kovacikova M, Stich V, Langin D (2010) Adipokines and dietary interventions in human obesity. Obes Rev 11:446–456. doi:10.1111/j.1467-789X.2009.00704.x

    Article  PubMed  CAS  Google Scholar 

  20. Körner A, Kratzsch J, Gausche R et al (2007) New predictors of the metabolic syndrome in children—role of adipocytokines. Pediatr Res 61:640–645

    PubMed  Google Scholar 

  21. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al (2000) CDC growth charts: United States. Adv Data 314:1–28

    PubMed  Google Scholar 

  22. Lara-Castro C, Yuchang F, Chung H, Garvey WT (2007) Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18:253–270

    Article  Google Scholar 

  23. Mathews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412–419

    Article  Google Scholar 

  24. McCarthy HD, Jarret KV, Crawley HF (2001) The development of waist circumference percentiles in British children aged 5.0–16.9y. Eur J Clin Nutr 55:902–907

    Article  PubMed  CAS  Google Scholar 

  25. Monzavi R, Dreimane D, Geffner ME et al (2006) Improvement in risk factors for metabolic syndrome and insulin resistance in overweight youth who are treated with lifestyle intervention. Pediatrics 117:e1111–e1118

    Article  PubMed  Google Scholar 

  26. Nagaya N, Kojima M, Uematsu M et al (2001) Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regulatory Integrative Comp Physiol 280:R1483–R1487

    CAS  Google Scholar 

  27. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 14:555–576

    Article  Google Scholar 

  28. Pedrosa C, Correia F, Seabra D et al (2009) Prevalence of overweight and obesity among 7–9 year-old children in Aveiro, Portugal: comparison between IOTF and CDC references. Public Health Nutr. doi:10.1017/S1368980009991789

  29. Raitakari OT, Porkka KVK, Riinnemaa T et al (1995) The role of insulin in clustering of serum lipids and blood pressure in children and adolescents—The Cardiovascular Risk in Young Finns Study. Diabetologia 38:1042–1050

    Article  PubMed  CAS  Google Scholar 

  30. Reinehr T, de Sousa G, Toschke AM, Andler W (2007) Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach. Arch Dis Child 92:1067–1072

    Article  PubMed  Google Scholar 

  31. Reinehr T, Kleber M, Toschke AM (2009) Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis 207:174–180

    Article  PubMed  CAS  Google Scholar 

  32. Saland JM (2007) Update on the metabolic syndrome in children. Curr Opin Pediatr 19:183–191

    Article  PubMed  Google Scholar 

  33. Semiz S, Rora S, Özdemir Ö et al (2008) Are C-reactive protein and homocysteine cardiovascular risk factor in obese children and adolescents? Pediatr Int 50:419–423

    Article  PubMed  CAS  Google Scholar 

  34. Steinberger J, Steffen L, Jacobs DR et al (2003) Relation of leptin to insulin resistance syndrome in children. Obes Res 11:1124–1130

    Article  PubMed  CAS  Google Scholar 

  35. Sung RYT, Yu CW, Chang SKY et al (2002) Effects of dietary intervention and strength training on blood lipid level in obese children. Arch Dis Child 86:407–410

    Article  PubMed  CAS  Google Scholar 

  36. Tanner J (1962) Growth at adolescence, 2nd edn. Blackwell Scientific, Oxford

    Google Scholar 

  37. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diab Care 26:3160–3167

    Article  Google Scholar 

  38. Valle M, Martos R, Gascón F et al (2005) Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab 31:55–62

    Article  PubMed  CAS  Google Scholar 

  39. Vasseur F, Meyre D, Froguel P (2006) Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med 8:1–12

    Article  PubMed  Google Scholar 

  40. Wang Y, Lobstein T (2006) Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 1:11–25

    Article  PubMed  Google Scholar 

  41. Wärnberg J, Marcos A (2008) Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol 19:11–15

    Article  PubMed  Google Scholar 

  42. Wauters M, Considine RV, Van Gaal LF (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143:293–311

    Article  PubMed  CAS  Google Scholar 

  43. Weiss R, Dziura J, Burget TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362–2374

    Article  PubMed  CAS  Google Scholar 

  44. Whatmore AJ, Hall CM, Jones J et al (2003) Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol 59:649–654

    Article  CAS  Google Scholar 

  45. Whitehead JP, Richards AA, Hickman IJ et al (2006) Adiponectin—a key adipokine in the metabolic syndrome. Diabetes Obes Metab 8:264–280

    Article  PubMed  CAS  Google Scholar 

  46. World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452

    Google Scholar 

  47. Yamauchi T, Kadowaki T (2008) Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes 32:s13–s18

    Article  CAS  Google Scholar 

  48. Yoshinaga M, Sameshima K, Tanaka Y et al (2008) Adipokines and the prediction of the accumulation of cardiovascular risk factors or the presence of metabolic syndrome in elementary school children. Circ J 72:1874–1878

    Article  PubMed  CAS  Google Scholar 

  49. Zimmet P, Alberti G, Kaufman F et al (2007) The metabolic syndrome in children and adolescents. Lancet 23:2059–2061

    Article  Google Scholar 

Download references

Acknowledgements

We thank the children and the parents who participated in the study. We also like to thank to the nurse Fernanda Gomes for assistance and to the endocrinologist Joana Guimarães for review and comments. This work was supported by a Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo/ABBOTT grant.

Conflict of interest

None.

Ethical standards

The research protocol was approved by the Ethics Committee of the Hospital Infante D. Pedro and informed consent was obtained from the children’s parents.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carla Pedrosa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pedrosa, C., Oliveira, B.M.P.M., Albuquerque, I. et al. Metabolic syndrome, adipokines and ghrelin in overweight and obese schoolchildren: results of a 1-year lifestyle intervention programme. Eur J Pediatr 170, 483–492 (2011). https://doi.org/10.1007/s00431-010-1316-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-010-1316-2

Keywords

Navigation